ALLR - Allarity Therapeutics, Inc.
1.05
-0.020 -1.905%
Share volume: 382,474
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.07
-0.02
-0.02%
Summary score
43%
Profitability
35%
Dept financing
40%
Liquidity
48%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-27.62%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
94.5%
Debt ratio change over timeo
0%
Current Ratio
0.97%
Quick Ratio
0%
Cash Position Ratio
0.75%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-24.52%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
36.45%
Debt ratio change over timeo
0%
Current Ratio
2.47%
Quick Ratio
0%
Cash Position Ratio
2.19%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-9.74%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
37.2%
Debt ratio change over time
0%
Current Ratio
2.66%
Quick Ratio
0%
Cash Position Ratio
2.28%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALLR | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 0% |
| Return on assets | -27.62% | 4.23% | 3.2% | 0% |
| Return on sales | 0% | 27.89% | 25.03% | 0% |
| Return on invested capital | 0% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 94.5% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 0% |
| Dept financing | 50% | 22% | 16% | 0% |
| Current Ratio | 2.47% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 2.19% | 0.12% | 0.5% | 0% |
| Liquididy | 45% | 53% | 69% | 0% |
| Short-term ratios | ALLR | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -24.52% | 4.32% | 3.49% | 0% |
| Return on sales | 0% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 36.45% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 36% | 25% | 18% | 0% |
| Current Ratio | 2.47% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 2.19% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 39% | 40% | 0% |
